Create issue ticket

4,425 Possible Causes for Parkinson's Disease, Progressive Disease

  • Progressive Supranuclear Palsy

    The current gold standard for measuring clinical disease progression in PSP is the PSP Rating Scale score.[ncbi.nlm.nih.gov] P/M, pons to midbrain ratio; PD, idiopathic Parkinson's disease; PSP-RS, Progressive Supranuclear Palsy-Richardson's Syndrome; Parkinson's disease; Progressive Supranuclear[ncbi.nlm.nih.gov] The ability to assess the distribution and extent of tau pathology in Alzheimer's disease and progressive supranuclear palsy in vivo would help to develop biomarkers for these[ncbi.nlm.nih.gov]

  • Amyotrophic Lateral Sclerosis

    This review examined current research related to moderate exercise for maintaining independence without accelerating disease progression in persons with ALS.[ncbi.nlm.nih.gov] Amyotrophic lateral sclerosis (ALS) and Parkinson's disease, both progressive neurodegenerative diseases, affect 1 million Americans (1,2).[ncbi.nlm.nih.gov] PMID: 19556916 Issn Print: 1557-0576 Publication Date: 2009/06/01 Checking for direct PDF access through Ovid Abstract Amyotrophic lateral sclerosis (ALS) is an idiopathic disease[doi.org]

  • Alzheimer Disease

    BACKGROUND AND OBJECTIVE: Semantic memory measures may be useful in tracking and predicting progression of Alzheimer disease.[ncbi.nlm.nih.gov] Parkinson's Disease Rating Scale; MMSE: Mini-Mental State Examination; PD: Parkinson disease; PDD: Parkinson disease dementia.[ncbi.nlm.nih.gov] Alzheimer’s is a progressive disease. This means that gradually, over time, more parts of the brain are damaged.[alzheimers.org.uk]

  • Classic Progressive Supranuclear Palsy Syndrome

    Not Applicable tideglusib;tideglusib;placebo 44 Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy Completed NCT02734485 Not[malacards.org] Neuropsychological characterization of typical and atypical progressive supranuclear palsy and comparison with Parkinson's disease.[minerva-access.unimelb.edu.au] A whole-brain analysis in de novo Parkinson disease. Am. J.[journal.frontiersin.org]

  • Young-Onset Parkinson Disease

    YOPD has a slower disease progression and a greater incidence and earlier appearance of levodopa-induced motor complications; namely, motor fluctuations and dyskinesias.[dovepress.com] Fourteen autobiographies written by individuals living with young-onset Parkinson's disease were also used as data sources.[ncbi.nlm.nih.gov] Parkinson’s treatment aims to slow the disease’s progression.[healthline.com]

  • Parkinson's Disease

    This study assessed the effect of levodopa on the rate of progression of Parkinson's disease.[ncbi.nlm.nih.gov] So far no laboratory tests exist for diagnosing Parkinson's disease.[symptoma.com] Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study.[nejm.org]

  • Parkinson's Disease Type 3

    However, symptoms vary and may worsen as the disease progresses.[healthline.com] Parkinson's disease type 3 (PD3) is a form of Parkinson's disease that is inherited in an autosomal dominant manner.[symptoma.com] It tends to be less responsive to typical Parkinson’s disease medication especially as it progresses.[parkinsonsnewstoday.com]

  • Parkinson-Dementia Syndrome

    Parkinson's disease is progressive: It gets worse over time.[everydayhealth.com] Murat Emre OUP Oxford, ٠٨‏/٠١‏/٢٠١٥ - 320 من الصفحات In this edited volume, experts on the treatment of dementia associated with Parkinson's Disease (PD) describe in detail[books.google.com] disease, dementia associated with Parkinson disease, dementia in Parkinson disease, and dementia with parkinsonism.[medlink.com]

  • Degenerative Brain Disorder

    "This is a rapidly progressing disease, so any drug that could slow down the degenerative process would give people the option to live longer."[news.xinhuanet.com] Can Phosphatidylserine Fight Parkinson's Disease? The researchers believe that phosphatidylserine could help treat other neurodegenerative diseases, like Parkinson's.[medicaldaily.com] progression.3-5With markers of clinical disease progression integral to the measurement of efficacy of disease-modifying therapies, a team of investigators led by Professor[quanterix.com]

  • Striatonigral Degeneration

    The performance of patients with SND was also compared with that of 14 patients with Parkinson's disease and 14 patients with progressive supranuclear palsy (PSP) matched[ncbi.nlm.nih.gov] Calcineurin immunoreactivity was densely distributed throughout the substantia nigra of patients with Parkinson's disease and control subjects.[ncbi.nlm.nih.gov] progression are unclear.[ncbi.nlm.nih.gov]

Further symptoms

Similar symptoms